Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
30 hedge funds and large institutions have $4.85M invested in Pernix Therapeutics Holdings, Inc. in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.
0% more call options, than puts
Call options by funds: $79K | Put options by funds: $79K
6% less funds holding
Funds holding: 32 → 30 (-2)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
20% less capital invested
Capital invested by funds: $6.09M → $4.85M (-$1.24M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$265K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$57.1K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$32.4K |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$28.6K |
| 5 |
BlackRock
New York
|
+$7.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$77K |
| 2 |
DTL
Dynamic Technology Lab
Singapore
|
-$37K |
| 3 |
Morgan Stanley
New York
|
-$20.7K |
| 4 |
SC
Searle & Co
Greenwich,
Connecticut
|
-$10.9K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$4.44K |
PTX Hedge Fund Activity: Q4 2017 in Review
30 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q4 2017, worth a combined $4.85M — down 20% from $6.09M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PTX and 2 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 5 added.
The largest buyer was Renaissance Technologies, adding an estimated $265K. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $77K sold.
- 30 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q4 2017, down from 32 in Q3 2017.
- Funds reported $4.85M of Pernix Therapeutics Holdings, Inc. stock for Q4 2017, down 20% quarter-over-quarter.
- 2 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q4 2017 and 4 closed out, a net change of -2 holders.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q4 2017 was Renaissance Technologies, an estimated $265K added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q4 2017 was Bank of New York Mellon, an estimated $77K sold.
Based on aggregated 13F filings for Q4 2017.